James Walker: Unscripted

Fieldpoint Private's new expert team targets complex deposits, a strategic move to deepen client relationships and carve out a competitive edge in banking.

With key hires in finance, regulatory, and manufacturing, Cyllene Therapeutics signals it's preparing for the big leagues. But can it deliver?

Atmofizer Technologies is cleaning its books and funding its partner in a complex deal to bring decocainized coca extract to the public market via an RTO.

Beyond the shareholder payout, OFG Bancorp's latest dividend reflects robust financial health, savvy strategy, and the resilience of its Caribbean markets.

Vibrantz Technologies' $200M deal with Finacity isn't just a loan; it's a masterclass in using receivables to fuel global growth amid financial pressure.

A new report gives T-Mobile a perfect score, but the real story is a new benchmark for 'AI-Readiness' that redefines what makes a mobile network great.

With an oversubscribed $130M Series B, Crystalys Therapeutics is accelerating its gout drug, dotinurad. But can it win the race to serve millions?

GoldMining Inc. unveils a compelling economic case for its São Jorge gold project in Brazil, but the path from promising study to profitable mine is fraught with risk.

As Qlosi refill rates hit 49%, Orasis shuns telehealth trends, investing in programs that put eye care professionals back at the center of care.

YPulse's new MCP tool connects its 21 billion datapoints on youth culture to AI like ChatGPT, aiming to replace marketing assumptions with verifiable data.

Homeowners are sitting on trillions in equity but are locked in by low mortgage rates. Gershman Mortgage's new 5-Day HELOC offers a solution.

Ottawa extends Babcock Canada’s submarine support contract by six years, a $1.1B deal vital for the current fleet and the transition to a new generation.

Amidst government announcements, a modest 2% CCB increase offers a lesson in the power of incremental policy and its real-world effect on family finances.

With record $4B revenue, Alcoa makes its biggest move yet, acquiring South32 assets to become a bauxite titan while investing in future-proof tech.

Surpassing 4 million users and winning a prestigious API World award, Bruno is challenging giants with a simple idea: API collections should be files.

Uniting two Texas title giants, Stewart's acquisition of Rattikin leverages deep historical ties to dominate the booming North Texas real estate landscape.

Medusind brings on AI veteran Raju Siva as its first Chief AI Officer, a strategic move to tackle the growing complexity and cost of healthcare billing.

Fresh off a massive Moderna settlement, Arbutus Biopharma expands its patent war against Pfizer and plans a $230M shareholder return, a bold strategic move.

The workforce giant's Q2 results reveal a masterclass in strategic execution, leveraging AI and smart divestitures to engineer a major comeback.

A new treatment, Junera™, isn't just about smoother skin. It signals a major shift in how the beauty industry operates, blending advanced biostimulation with powerful physician networks.